下载掌阅APP，畅读海量书库
立即打开
［1］GONG Q，ZHANG P，WANG J，et al.Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance:30-year results of the Da Qing Diabetes Prevention Outcome Study［J］.Lancet Diabetes Endocrinol，2019，7（6）：452-461.
［2］KNOWLER W C，BARRETT-CONNOR E，FOWLER S E，et al.Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin［J］.N Engl J Med，2002，346（6）：393-403.
［3］DIABETES PREVENTION PROGRAM RESEARCH GROUP.Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up:the Diabetes Prevention Program Outcomes Study［J］.Lancet Diabetes Endocrinol，2015，3（11）：866-875.
［4］中华医学会内分泌学分会，中华医学会糖尿病学分会，中国医师协会内分泌代谢科医师分会，等.中国成人糖尿病前期干预的专家共识［J］.中华内分泌代谢杂志，2020，36（5）：371-380.
［5］中华人民共和国卫生部.糖尿病筛查和诊断：WS 397—2012［S］.北京：中国标准出版社，2012.
［6］JIA W P，PANG C，CHEN L，et al.Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population:the Shanghai Diabetes Studies，a cross-sectional 3-year follow-up study in Shanghai urban communities［J］.Diabetologia，2007，50（2）：286-292.
［7］NATHAN D M，CLEARY P A，BACKLUND J Y，et al.Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes［J］.N Engl J Med，2005，353（25）：2643-2653.
［8］HOLMAN R R，PAUL S K，BETHEL M A，et al.10-year follow-up of intensive glucose control in type 2 diabetes［J］.N Engl J Med，2008，359（15）：1577-1589.
［9］PATEL A，MACMAHON S，CHALMERS J，et al.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes［J］.N Engl J Med，2008，358（24）：2560-2572.
［10］GERSTEIN H C，MILLER M E，BYINGTON R P，et al.Effects of intensive glucose lowering in type 2 diabetes［J］.N Engl J Med，2008，358（24）：2545-2559.
［11］DUCKWORTH W，ABRAIRA C，MORITZ T，et al.Glucose control and vascular complications in veterans with type 2 diabetes［J］.N Engl J Med，2009，360（2）：129-139.
［12］UK PROSPECTIVE DIABETES STUDY GROUP.Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 38［J］.BMJ，1998，317（7160）：703-713.
［13］COLLINS R，ARMITAGE J，PARISH S，et al.MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes:a randomised placebo-controlled trial［J］.Lancet，2003，361（9374）：2005-2016.